Karin Jooss Net Worth & Insider Trades

Karin Jooss - Director, Fate Therapeutics Inc

As of June 13, 2022

What is Karin Jooss's Net Worth?

The current estimated net worth of Fate Therapeutics Inc's Director, Karin Jooss, is estimated to be about $836.17K . Karin Jooss owns about 1,198 units of Fate Therapeutics Inc common stock. In the last 3 years at Fate Therapeutics Inc, Karin Jooss has sold an estimated value of $33.84K worth.

What is Karin Jooss's Past Insider Trading?

Karin Jooss's largest sale order was 1,483 units , worth over $33.84K on June 6, 2022. In total, Karin Jooss has made about 6 transactions over 3 years of their time at Fate Therapeutics Inc. Karin Jooss usually trades in June, with the busiest year in 2019 and 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Karin Jooss's' Mailing Address?

  • Mailing address is C/o Gritstone Oncology, Inc. 5858 Horton Street, Suite 210 Emeryville CA 94608 CA

Fate Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
J. Scott Wolchko 2020 $570,000 - $1,451,340 $3,222,577 $356,250 - $5,600,167
J. Scott Wolchko 2019 $540,000 - $4,137,500 $5,732,955 $310,500 - $10,720,955
J. Scott Wolchko 2018 $516,000 - - $2,756,998 $258,000 - $3,530,998
Edward J. Dulac III 2020 $142,500 $137,917 $1,420,800 $3,786,529 $75,833 $120,000 $5,683,579
Bahram Valamehr, Ph.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Bahram Valamehr, Ph.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Bahram Valamehr, Ph.D. 2018 $321,865 - - $2,138,235 $117,250 - $2,577,350
Cindy R. Tahl, J.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Cindy R. Tahl, J.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Cindy R. Tahl, J.D. 2018 $350,000 - - $906,465 $122,500 - $1,378,965
Daniel D. Shoemaker, Ph.D. 2020 $390,000 - $549,750 $1,324,347 $195,000 - $2,459,097
Daniel D. Shoemaker, Ph.D. 2019 $375,000 - $744,750 $1,547,898 $150,938 - $2,818,586
Daniel D. Shoemaker, Ph.D. 2018 $365,000 - - $842,338 $127,750 - $1,335,088
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1434316/000119312521124699/d85377ddef14a.htm

What are Fate Therapeutics Inc's Past Insider Trades?

Fate Therapeutics Inc's most recent insider trade came on August 19, 2022 by Edward Dulac III who sold 5,135 units worth $153.05K . In the last 9 years, insiders at Fate Therapeutics Inc have sold an estimated value of $126.53M and bought an estimated value of $170.91M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Scott Wolchko, President and CEO,  Cindy Tahl, General Counsel and Secretary,  and Amir Nashat, Director .

FATE THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1